AKT1 and breast cancer: This makes the PI3K/Akt/mTOR pathway a crucial object of study for understanding the development and progression of this disease, the role of this pathway as a potential therapeutic target, and the prognostic and diagnostic value of this pathway in patients with breast cancer [32, 33].